Home
About
Product
News
Honor
Contact
Purchasing
Company News
Industry trends
Purchasing information
2017-12-11
According to the Metropolitan Metro News, a new report shows that the price of a cancer drug has risen by nearly 1400% in just five years. According to the Wall Street Journal, Lomustine is a drug for treating lymphoma and brain tumors. Its current price is $768, compared with $50 in 2013. The price of the drug rose steadily after it was acquired by NextSource Pharmaceutical Company in 2013. Because there was no alternative drug, some cancer patients had to bear huge drug costs, while some patients stopped taking the drug because they could not afford it. NextSource Chief Executive
2017-12-29
Congratulations on the establishment of our website
2017-07-18
The 17th World Pharmaceutical Raw Materials China Exhibition
2017-07-21
Zhao Tao, Chairman of Buchang Pharmaceutical, took a group photo with the Chairman of the Company to discuss the project
2017-10-30
The 79th China International Trade Fair for Pharmaceutical Raw Materials, Intermediates, Packaging and Equipment
2017-11-23
2017 International Pharmaceutical Raw Materials Exhibition World Pharmaceutical Machinery Packaging Equipment and Materials India Exhibition
The drug factory increased the price of life-saving cancer drugs by 1400% in five years